# Boston Scientific to acquire Apama Medical for up to $300 million

Boston Scientific has agreed to acquire Apama Medical, a developer of the Apama Radiofrequency Balloon Catheter System for treating atrial fibrillation, for $175 million upfront plus up to $125 million in contingent payments.

- Type: Acquisition
- Announced: 2017-10-02
- Where: United States
- Value: $300.0M
- Status: announced
- Products: radiofrequency balloon catheter system for atrial fibrillation
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Boston Scientific](https://endata.com/companies/15966.md) (acquirer)
- [Apama Medical](https://endata.com/companies/27289.md) (target)

## Sources

- [news.bostonscientific.com](https://news.bostonscientific.com/2017-10-02-Boston-Scientific-Announces-Agreement-to-Acquire-Apama-Medical), 2017-10-02: "The acquisition of Apama further advances our continued investment in the electrophysiology category, and, upon commercialization, would broaden our portfolio of differentiated arrhythmia solutions."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.